Introduction {#Sec1}
============

The type VI secretion system (T6SS) is a widespread nanomachine bearing considerable structural and mechanistic similarity to contractile phage tails \[[@CR1]--[@CR3]\]. T6SSs are employed as offensive or defensive tools to kill prokaryotic or eukaryotic target cells or to acquire metal ions to overcome stress conditions, respectively \[[@CR4]--[@CR6]\]. The T6S apparatus is comprised of a cytoplasmic tubule---made of an inner tube enclosed in a contractile sheath---and an envelope spanning membrane complex that are connected by a base plate \[[@CR7]\]. Contraction of the sheath acts as a molecular spring that pushes the inner tube tipped with a spike protein into the extracellular milieu or into the target cell, thereby translocating effector proteins \[[@CR8]\]. The contracted sheath remains in the cytoplasm and is recycled by the ring-forming AAA^+^ ATPase ClpV enabling a new assembly-contraction-disassembly cycle \[[@CR9]--[@CR11]\]. ClpV of *Vibrio cholerae* interacts directly with the N-terminus of the sheath protein TssC that is exposed in its contracted state \[[@CR11]--[@CR14]\]. Fluorescent protein fusions to ClpV of T6SSs targeting bacterial cells showed that the protein localizes to dynamic foci, which is dependent on components of the T6SS \[[@CR9], [@CR15], [@CR16]\]. Localization dynamics of ClpV foci are associated with lysis or blebbing of the neighboring target cell indicating a prior translocation event \[[@CR9], [@CR17]\].

*Burkholderia thailandensis* is a soil saprophyte able to switch to an intracellular life style upon contact with phagocytic and non-phagocytic cells \[[@CR18], [@CR19]\]. The bacteria encode multiple T6SSs belonging to the canonical T6SS^i^ subtype \[[@CR20]\], \[[@CR21]\]. The T6SS-5, which is expressed during infection of host cells, induces the formation of multinucleated giant cells (MNGCs) for intercellular spread of the bacteria and the T6SS-1 is involved in interbacterial interactions \[[@CR18], [@CR22], [@CR23]\]. This work extends a previous study showing that the ATPase of the T6SS-1 (ClpV-1) and T6SS-5 (ClpV-5) localizes to distinctly different sites inside *B.* *thailandensis* \[[@CR16]\]. In contrast to ClpV-5-GFP foci, which were predominantly found at one or both cell poles, ClpV-1-GFP foci localized in a nearly random manner along the cell length, similar to ClpV of other bacterial cell targeting T6SS. In addition, ClpV-1-GFP foci are more dynamic than ClpV-5-sfGFP foci \[[@CR16]\]. The mechanism underlying the differential localization pattern is not known. Here, we imaged a ClpV-5-sfGFP fusion protein in *B. thailandensis* harboring a deletion of the entire T6SS-5 gene cluster to investigate if T6SS-5 apparatus proteins direct ClpV-5 to the pole. We found that the polar localization of ClpV-5 is not dependent on the interaction with other T6SS-5 proteins.

Main text {#Sec2}
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Methods {#Sec3}
-------

### Bacterial strains and growth conditions {#Sec4}

*Escherichia coli* DH5α and SM10λpir and *B. thailandensis* E264 were routinely grown in Luria--Bertani (LB) medium at 37 °C supplemented with 200 μg/ml trimethoprim and 0.02% rhamnose when necessary.

### Construction of plasmids and *B. thailandensis* mutants {#Sec5}

*Burkholderia thailandensis* ΔT6SS-5 carrying an unmarked deletion of the T6SS-5 gene cluster (BTH_II0855-BTH_II0873) and *B. thailandensis* expressing a chromosomal fusion of *mCherry* to *clpV*-*5* at the native site (*clpV*-*5*-*mCherry*) were generated using the suicide vector pJRC115 as described previously \[[@CR23], [@CR24]\]. The mini-Tn*7* transposon delivery plasmid pUC18T-mini-Tn*7*T-Tp was used for expression of *clpV*-*5*-*sfgfp* from a neutral chromosomal site in ΔT6SS-5. The gene *clpV*-*5* (BTH_II0864) fused to *sfgfp* was cloned into pUC18T-mini-Tn*7*T-Tp::*P*~S12~ to express *clpV*-*5*-*sfgfp* under control of the constitutive ribosomal promoter *P*~S12~ (BaseClear) \[[@CR23], [@CR25]\]. Transformation of *B.* *thailandensis* ΔT6SS-5 with this and the transposase helper plasmid pTNS3 yielded the mutant ΔT6SS-5 *att*Tn*7*::*P*~S12~-*clpV*-*5*-*sfgfp*, which we termed T6SS-5^−^ *clpV*-*5*-*sfgfp*. *B.* *thailandensis* expressing a chromosomal fusion of *clpV*-*5*-*sfgfp* (T6SS-5^+^ *clpV*-*5*-*sfgp*) was generated in previous work \[[@CR16]\]. The genes *virA* (BTH_II0871) and *virG* (BTH_II0872) encoding the two component system VirAG were cloned into the expression vector pSCrhaB2 carrying a rhamnose inducible promoter (p::*virAG*) \[[@CR26]\].

### Infection of RAW 264.7 macrophages and fluorescence microscopy {#Sec6}

The RAW 264.7 murine macrophage cell line (ATCC) and the Hela epithelial cell line (ATCC) were maintained in high glucose DMEM supplemented with 1 mM sodium pyruvate and 10% fetal bovine serum (Gibco) at 37 °C and 5% CO~2~. On the day before the experiment 1 × 10^5^ macrophages and 5 × 10^4^ Hela cells were seeded on glass cover slips in 24 well plates. The cells were infected with *B. thailandensis* wild type and mutants harvested from exponential phase cultures at multiplicity of infection (MOI) 2 (macrophages) and 50 (Hela cells) and incubated for 1 h. The medium was replaced with fresh DMEM containing 100 μg/ml imipenem followed by 13 h incubation. At this time point the macrophages were stained with Giemsa (Sigma) and viewed with a Olympus BX51 microscope and a 20 × (for quantification of MNGC formation) and 40 × (for images shown in Fig. [1](#Fig1){ref-type="fig"}b) objective. MNGC formation was quantified using the formula: (number of nuclei within MNGCs/total number of nuclei) × 100. For epifluorescence microscopy, macrophages were infected with *B.* *thailandensis* at MOI 50 for 6 h and fixed with 4% formaldehyde. F-actin and DNA was stained with Texas Red-X Phalloidin or Alexa Fluor 488 Phalloidin and 4′,6-diamidino-2-phenylindole (DAPI), respectively. Images of cells were acquired with a Nikon Eclipse Ti-E equipped with a CCD Hamamatsu Orca Flash 4.0 camera and a CFI Plan-Apo DM 100×/1.45 Oil Ph3 objective.Fig. 1Verification of *B. thailandensis* T6SS-5^−^ *clpV*-*5*-*sfgfp* and T6SS-5^+^ *clpV*-*5*-*sfgfp* mutants. **a** Confirmation of the deletion of the T6SS-5 gene cluster (size: \~ 28 kb) in *B.* *thailandensis* by PCR using genomic DNA of the indicated strains and primers specific for the T6SS-5 gene *hcp*-*5* (yielding a 489 bp product for the wild type and no amplicon for the ΔT6SS-5 mutant) and genes flanking the T6SS-5 gene cluster (yielding a 28,201 bp and 1885 bp product for the wild type and ΔT6SS-5 mutant, respectively). **b** Representative images of RAW264.7 macrophages infected with *B.* *thailandensis* ΔT6SS-5 *att*Tn7::*P*~S12~\_*clpV*-*5*-*sfgfp* (T6SS-5^−^ *clpV*-*5*-*sfgfp*) and a strain expressing a chromosomal *clpV*-*5*-*sfgfp* fusion (T6SS-5^+^ *clpV*-*5*-*sfgfp*) at MOI 2 for 13 h and stained with Giemsa. **c** Quantification of MNGC formation of RAW264.7 macrophages infected with the indicated *B.* *thailandensis* strains and stained as described in B. The ability of the T6SS-5^+^ *clpV*-*5*-*sfgfp* mutant to induce MNGC formation shows that ClpV-5 is functional when fused to sfGFP. The data shown are mean values +SD based on two experiments performed in triplicate and three randomly selected microscopic fields per sample (N \> 7578 nuclei). ns, not significant/*P* = 0.498 (t-test); \*\*\*\**P* \< 0.0001 (Welch's t-test). **d** Detection of ClpV-5-sfGFP fusion proteins in whole cell lysates of the indicated *B.* *thailandensis* strains by Western blot analysis using α-GFP antibody (MW: GFP, 27 kDa; ClpV-5, 101 kDa) and as loading control α-RpoB antibody (MW: RpoB, 153 kDa). The bacteria were grown to an OD~600nm~ of 1.0 in LB broth. The genes BTH_II0871 and BTH_II0872 encoding the two component system VirAG were overexpressed (p::*virAG*) in *B.* *thailandensis* T6SS-5^+^ *clpV*-*5*-*sfgfp* to induce production of the fusion protein outside the host cell environment

### Western blot {#Sec7}

*Burkholderia thailandensis* strains were grown in LB broth supplemented with 0.02% rhamnose and 200 μg/ml trimethoprim where necessary. A 1 ml aliquot of bacterial cultures grown to an OD~600nm~ of 1.0 was centrifuged and the cell pellet was resuspended in H~2~O and Laemmli sample buffer. Following SDS PAGE the samples were transferred to nitrocellulose membranes, which were blocked with 5% skim milk and probed with the primary antibodies mouse monoclonal anti-GFP (Thermo Fisher; MA5-15256) or mouse monoclonal anti-RNA polymerase beta (Thermo Fisher; MA1-25425). HRP-conjugated rabbit anti-mouse (Thermo Fisher; 31457) was used as secondary antibody. Blots were developed using Clarity Western ECL substrate (Biorad).

### Statistical analysis {#Sec8}

The t-test or Welch's t-test was performed to test the difference between two means as indicated in the figure legends. A *P* value of ≤ 0.05 was considered statistically significant.

Results and discussion {#Sec9}
----------------------

To examine whether ClpV-5 localizes to the pole by interacting with protein(s) of the T6SS-5 apparatus, we constructed an unmarked deletion mutant of the entire T6SS-5 gene cluster (BTH_II0855--BTH_II0873) in *B.* *thailandensis*. This mutant lacks all components of the T6SS-5 secretion apparatus. ClpV-5 localization analysis in the absence of T6SS-5 components was performed by integrating a *clpV*-*5*-*sfgfp* fusion gene into the chromosome of the ΔT6SS-5 mutant under control of a constitutive promoter using the mini-Tn*7* system (T6SS-5^−^ *clpV*-*5*-*sfgfp*). Deletion of the T6SS-5 gene cluster was confirmed by PCR and the inability of the T6SS-5^−^ *clpV*-*5*-*sfgfp* mutant to induce MNGC formation of RAW 264.7 macrophages (Fig. [1](#Fig1){ref-type="fig"}a--c). As control, bacteria expressing a chromosomal *clpV*-*5*-*sfgfp* fusion in the wild type genetic background were used (T6SS-5^+^ *clpV*-*5*-*sfgfp*). The capability of this mutant to mediate MNGC formation at levels similar to the wild type demonstrates that ClpV-5 is functional when fused to sfGFP (Fig. [1](#Fig1){ref-type="fig"}b, c). Production of the ClpV-5-sfGFP fusion protein by *B. thailandensis* T6SS-5^−^ *clpV*-*5*-*sfgfp* and T6SS-5^+^ *clpV*-*5*-*sfgfp* was confirmed by Western blot analysis (Fig. [1](#Fig1){ref-type="fig"}d). To this end, cell lysates of bacteria grown in LB broth were used. Transcription of *clpV*-*5*-*sfgfp* in T6SS-5^+^ *clpV*-*5*-*sfgfp* was achieved by overexpression of the two component regulatory genes *virAG* (p::*virAG*) previously shown to stimulate the T6SS-5 under conditions that lack the native host cell derived activation signal \[[@CR16], [@CR27], [@CR28]\]. Furthermore, we investigated the localization of ClpV-5 fused to the monomeric fluorescent protein mCherry during infection of host cells. ClpV-5-mCherry localizes to single discrete foci at the pole of *B. thailandensis* thus verifying the localization pattern observed for ClpV-5-sfGFP (Additional file [1](#MOESM1){ref-type="media"}: Figure S1).

Given that the native environment for T6SS-5 expression and activity is the intracellular milieu of the host cell, we studied the localization of ClpV-5 within *B.* *thailandensis* during infection of RAW264.7 macrophages. The cells were infected with *B.* *thailandensis* T6SS-5^−^ *clpV*-*5*-*sfgfp* and as control with T6SS-5^+^ *clpV*-*5*-*sfgfp*. In the T6SS-5^+^ genetic background giving rise to a complete and functional T6SS-5, the ClpV-5-sfGFP fusion protein displayed the formation of discrete foci and diffuse cytoplasmic localization as reported previously (Fig. [2](#Fig2){ref-type="fig"}a) \[[@CR16]\]. The majority of ClpV-5-sfGFP foci (81%) exhibited a polar localization (Fig. [2](#Fig2){ref-type="fig"}a, c). Interestingly, in the absence of all T6SS-5 components ClpV-5-sfGFP still assembled into foci located at the pole (Fig. [2](#Fig2){ref-type="fig"}b). Furthermore, the number of polar ClpV-5-sfGFP foci did not significantly differ between T6SS-5^+^ and T6SS-5^−^ bacteria (Fig. [2](#Fig2){ref-type="fig"}c). The non-native chromosomal position of *clpV*-*5*-*sfgfp* in the T6SS-5^−^ mutant did not abolish polar localization of the fusion protein. The data demonstrate that T6SS-5 apparatus protein(s) are not required for polar localization of ClpV-5-sfGFP. Instead, a non-T6SS protein may serve for example as a polar anchor for ClpV-5. The finding that T6SS-5 components are dispensable for ClpV-5 localization is consistent with reports showing that ClpV specifically interacts with the T6 apparatus following a secretion event, i.e. with the contracted sheath \[[@CR9]\]. Moreover, ClpV1 of the bacterial cell targeting T6SS of *E.* *coli* does not directly interact with any of the T6SS apparatus components except for TssC \[[@CR12]\]. On the other hand, the deletion of components of bacterial cell targeting T6SSs in *V.* *cholerae, Pseudomonas* *aeruginosa* and *Serratia marcescens* abrogated ClpV foci formation and resulted in a diffuse cytoplasmic localization \[[@CR9], [@CR15], [@CR29]--[@CR31]\]. Likewise, the ATPase ClpB of the anti-host but non-canonical T6SS in *Francisella novicida* requires the T6SS protein PdpB for localization \[[@CR32]\]. Altogether, the results suggest that complex and distinct localization mechanisms underlie the positioning of the ATPase of bacterial and host cell targeting T6SS.Fig. 2Polar localization of ClpV-5-sfGFP within *B. thailandensis* is not abolished in the absence of all T6SS-5 components. **a**, **b** RAW264.7 macrophages were infected with *B.* *thailandensis* **a** expressing a chromosomal *clpV*-*5*-*sfgfp* fusion in the wild type background (T6SS-5^+^ *clpV*-*5*-*sfgfp*) and **b** carrying a deletion of the entire T6SS-5 gene cluster and expressing *clpV*-*5*-*sfgfp* constitutively from a neutral site on the chromosome (T6SS-5^−^ *clpV*-*5*-*sfgfp*) at MOI 50 for 6 h. Host cell actin and DNA was stained with Texas Red-X Phalloidin and DAPI, respectively. Because the regulatory genes *virA/virG*, which are located within the T6SS-5 gene cluster, are required for activating the actin polymerization gene *bimA*, the T6SS-5^−^ mutant is unable to form actin tails. Scale bars, 5 μm and 1 μm for main figure and insets, respectively. **c** Quantification of ClpV-5-sfGFP foci displaying a polar localization in *B. thailandensis* T6SS-5^+^ *clpV*-*5*-*sfgfp* and T6SS-5^−^ *clpV*-*5*-*sfgfp* during infection of RAW264.7 macrophages. The data shown represent mean values +SD based on two experiments performed in duplicate and three randomly selected microscopic fields per sample (N ≥ 223 foci). ns, not significant/*P* = 0.156 (t-test)

Limitations {#Sec10}
===========

Fluorescent protein fusion, a widely used method for protein localization studies, was used to determine the subcellular localization of ClpV-5. A limitation of this technique is that the fluorescent protein might alter localization and activity of ClpV-5. The *clpV*-*5*-*sfgfp* fusion was expressed from the native chromosomal *clpV*-*5* locus activated by the native host cell signal and we confirmed that ClpV-5 was functional when fused to sfGFP. Moreover, a previous study utilizing ClpV specific antibodies showed that --like ClpV-5-sfGFP-- the native untagged ClpV protein assembles into discrete foci in *V.* *cholerae* \[[@CR29]\].

Additional file
===============

 {#Sec11}

**Additional file 1: Figure S1.** A ClpV-5-mCherry fusion protein localizes to the bacterial cell pole during infection of host cells. Phase contrast and fluorescence microscopy images of Hela cells infected with *B.* *thailandensis* expressing a chromosomal *clpV*-*5*-*mCherry* fusion at MOI 50 for 13 h. Host cell actin was stained with Alexa Fluor 488 Phalloidin. Scale bar, 2 μm.
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